Plug Power to Announce 2017 Second Quarter Results on August 8, 2017
Jul 31, 2017 11:00 am UTC| Business
LATHAM, N.Y., July 31, 2017 -- Plug Power Inc. (NASDAQ:PLUG), a leader in providing energy solutions that change the way the world moves, today confirms it will release the Company’s 2017 second quarter results on...
Sportsman’s Warehouse to Hold Grand Opening in Spokane Valley, Washington
Jul 31, 2017 11:00 am UTC| Business
MIDVALE, Utah, July 31, 2017 -- Sportsman’s Warehouse (NASDAQ:SPWH) is expanding its operations to include a new retail location in Spokane Valley, Washington. The grand opening will take place on Thursday August 3,...
Roper Technologies Announces Second Quarter Results
Jul 31, 2017 10:55 am UTC| Business
GAAP Revenue Increased 22%; Adjusted Revenue Increased 23% Raising Full Year Adjusted DEPS Guidance SARASOTA, Fla., July 31, 2017 -- Roper Technologies, Inc. (NYSE:ROP), a diversified technology company, reported...
Jul 31, 2017 10:50 am UTC| Business
PHOENIX, July 31, 2017 -- Insys Therapeutics, Inc. (NASDAQ:INSY) (“INSYS” or “the Company”) today announced that SYNDROS™ (dronabinol oral solution), a proprietary, orally administered liquid formulation of dronabinol,...
Sonoco’s 2016-2017 Corporate Responsibility Report shows steady progress
Jul 31, 2017 10:50 am UTC| Business
HARTSVILLE, S.C., July 31, 2017 -- Sonoco (NYSE:SON), one of the largest diversified global packaging companies, has released its 2016-2017 Corporate Responsibility Report. The report, which is available on the...
Scripps Networks Interactive, Inc. reports second quarter 2017 preliminary results
Jul 31, 2017 10:47 am UTC| Business
KNOXVILLE, Tenn., July 31, 2017 -- Scripps Networks Interactive, Inc. (Nasdaq:SNI) today reported second quarter 2017 preliminary results through income from operations before income taxes. The company will be reporting...
Loxo Oncology Announces Acquisition of Highly Selective, Reversible BTK Inhibitor Program
Jul 31, 2017 10:45 am UTC| Business
STAMFORD, Conn., July 31, 2017 -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, today announced...